Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
SECURITIES AND EXCHANGE COMMISSION v. COHEN et al
Case Number:
2:15-cv-01292
Court:
Nature of Suit:
Judge:
Government Agencies
-
July 09, 2018
Atty's Claims Back Up Penalties In Biotech Fraud, SEC Says
The U.S. Securities and Exchange Commission has renewed its demand for more than $1 million from a onetime biotech chief executive, telling a New Jersey federal court that his attorney confirmed he pocketed illicit proceeds from the sale of company stock.
-
February 23, 2018
No 'Rubber Stamp' For SEC Penalties In NJ Biotech Fraud Row
A New Jersey federal judge on Friday said she would not “rubber-stamp” the U.S. Securities and Exchange Commission's demand for more than $1 million from a onetime biotech chief executive without evidence to back up the agency's claims that he pocketed illicit proceeds from the sale of company stock.
-
February 19, 2015
Biotech CEO Admits Using Father-In-Law To Hide Sham Trades
The CEO of biotechnology company Proteonomix Inc. admitted in New Jersey federal court Thursday that he made $600,000 by funneling millions of Proteonomix shares to companies nominally under his father-in-law's control and then selling them on the open market.